Results 171 to 180 of about 57,313 (205)

Combination of cyclin-dependent kinase 4/6 inhibitors and renin-angiotensin system inhibitors in breast cancer treatment: a promising therapeutic approach. [PDF]

Rev Assoc Med Bras (1992)
Mutlu E, İnanç M.
europepmc   +1 more source

Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line. [PDF]

Transl Cancer Res
Liang H, Li Q, Liao Y, Huang H, Yang W, Li X, Chen G, Zhang C.   +7 more
europepmc   +1 more source

Evaluating the clinical utility of ctDNA testing to identify molecular cancer progression - lessons from SERENA-6. [PDF]

NPJ Breast Cancer
Taranto E, DeMichele A.
europepmc   +1 more source

The Multifaceted Role of Rad9 in the DNA Damage Response of Saccharomyces cerevisiae. [PDF]

Yeast
Kiely A, O'Halloran F, Young P, Lowndes NF, Grenon M, Finn K.   +5 more
europepmc   +1 more source

Cytoplasmic cyclin D1 modulates brain cortex development. [PDF]

Cell Mol Life Sci
Pedraza N, Rocandio D, Zammou B, Monserrat MV, Ortiz-Brugués A, Marfull-Oromí P, Chauhan D, Encinas M, Dolcet X, Ferrezuelo F, Garí E, Egea J.   +11 more
europepmc   +1 more source

The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast Cancer. [PDF]

Cancers (Basel)
Ohm H, Lohrisch C, LeVasseur N, Simmons C, Mitri ZI.   +4 more
europepmc   +1 more source

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial. [PDF]

Nat Med
Brastianos PK, Dooley K, Geyer S, Gerstner ER, Kaufmann TJ, Iafrate AJ, Martinez-Lage M, Milhem M, Welch MR, Kaley TJ, Drappatz J, Chan A, Kumthekar P, Matsuoka CK, Strowd RE, Cohen AL, Jaeckle K, Robell L, Magge RS, Nam JY, Blondin N, Shaikh N, Rabinowitz I, Thomas AA, Piccioni DE, Brown P, Kaluziak S, Codd E, Cahill DP, Santagata S, Barker FG, Galanis E.   +31 more
europepmc   +1 more source

Advantages of PROTACs in achieving selective degradation of homologous protein families. [PDF]

Beilstein J Org Chem
Yang L, Mao X, Zhang J, Shu J, Huang W, Dong X, Chen Y, Wu M.   +7 more
europepmc   +1 more source

From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2- breast cancer. [PDF]

Breast
Stachyra P, Hernando Meliá C, López-Guerrero JA, Gavilá Gregori J, Guerrero-Zotano ÁL.   +4 more
europepmc   +1 more source